Structural and functional conservation of the programmed −1 ribosomal frameshift signal of SARS coronavirus 2 (SARS-CoV-2)

Abstract

17 years after the SARS-CoV epidemic, the world is facing the COVID-19 pandemic. COVID-19 is caused by a coronavirus named SARS-CoV-2. Given the most optimistic projections estimating that it will take over a year to develop a vaccine, the best short-term strategy may lie in identifying virus-specific targets for small molecule interventions. All coronaviruses utilize a molecular mechanism called -1 PRF to control the relative expression of their proteins. Prior analyses of SARS-CoV revealed that it employs a structurally unique three-stemmed mRNA pseudoknot to stimulate high rates of -1 PRF, and that it also harbors a -1 PRF attenuation element. Altering -1 PRF activity negatively impacts virus replication, suggesting that this molecular mechanism may be therapeutically targeted. Here we present a comparative analysis of the original SARS-CoV and SARS-CoV-2 frameshift signals. Structural and functional analyses revealed that both elements promote similar rates of -1 PRF and that silent coding mutations in the slippery sites and in all three stems of the pseudoknot strongly ablated -1 PRF activity. The upstream attenuator hairpin activity has also been functionally retained. Small-angle x-ray scattering indicated that the pseudoknots in SARS-CoV and SARS-CoV-2 had the same conformation. Finally, a small molecule previously shown to bind the SARS-CoV pseudoknot and inhibit -1 PRF was similarly effective against -1 PRF in SARS-CoV-2, suggesting that such frameshift inhibitors may provide promising lead compounds to counter the current pandemic.

Cited by papers we hold 12

• Altered tRNA dynamics during translocation on slippery mRNA as determinant of spontaneous ribosome frameshifting · 2022
  Not checked
• An intranasal ASO therapeutic targeting SARS-CoV-2 · 2022
  Not checked
• Secondary structural ensembles of the SARS-CoV-2 RNA genome in infected cells · 2022
  No notice
• Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors · 2021
  No notice
• Comprehensive mapping of SARS-CoV-2 interactions in vivo reveals functional virus-host interactions · 2021
  Not checked
• The architecture of the SARS-CoV-2 RNA genome inside virion · 2021
  No notice
• Restriction of SARS-CoV-2 replication by targeting programmed −1 ribosomal frameshifting · 2021
  No notice
• Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome · 2021
  No notice
• The Short- and Long-Range RNA-RNA Interactome of SARS-CoV-2 · 2020
  No notice
• A drug screening toolkit based on the –1 ribosomal frameshifting of SARS-CoV-2 · 2020
  Not checked
• RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses: a first look · 2020
  No notice
• Crystal structures of SARS-CoV-2 ADP-ribose phosphatase: from the apo form to ligand complexes · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.